OpenResearchAlpha

bioRxiv · 18 Nov 2026

Sidetrak: a de novo-designed miniprotein targets the kinesin-1 coiled-coil stalk to inhibit MAP7 binding and disrupt mitochondrial transport

Jessica A Crossh-index 9, Sarah A Bristow, Thilani Babuji, Dek Woolfson, Mark P Doddingh-index 25

0
Citations
no database records one yet
0
Citations in 2026
so far
25
Leading author's h-index
Mark P Dodding, in QAI's scholar index
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

The coiled-coil domains of cytoskeletal motors contain regulatory surfaces that offer largely unexploited targets for manipulating intracellular transport. The microtubule-associated protein MAP7 promotes kinesin-1 motor activity, binding a coiled-coil surface that overlaps the TPR docking site (TDS), a regulatory interface involved in autoinhibition. Starting from an AlphaFold3 model of this relatively feature-poor surface, we used BoltzGen to design Sidetrak, a 36-amino acid miniprotein that binds kinesin-1 with nanomolar affinity. Binding requires the TDS and is abolished by mutation of the predicted Sidetrak interface, supporting the modelled local geometry of the targeted coiled-coil region. Sidetrak inhibits MAP7 binding, reduces MAP7-dependent kinesin-1 recruitment to microtubules in cells and causes perinuclear redistribution of mitochondria, a kinesin-1 cargo. Sidetrak binds all three kinesin-1 heavy-chain paralogues, and quantitative interaction proteomics revealed selective association with endogenous kinesin-1 complexes and associated cargo adaptors. These findings demonstrate selective disruption of a motor-MAP interaction by a de novo-designed protein and highlight regulatory coiled-coil surfaces as targets for manipulating intracellular transport. Beyond providing a means to manipulate intracellular transport, this work illustrates the potential of de novo protein design to test structural models of protein interfaces and probe endogenous protein networks to uncover underlying cellular mechanisms.

Cell biology

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Mark P Dodding has the highest h-index among the authors (25).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (5)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.
Sidetrak: a de novo-designed miniprotein targets the kinesin-1 coiled-coil stalk to inhibit MAP7 binding and disrupt mitochondrial transport - QAI OpenResearch